-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
-
Summary
-
Chemomab Therapeutics Ltd. quarterly Common Stock, Value, Issued history and growth rate from Q4 2019 to Q2 2024.
- Chemomab Therapeutics Ltd. Common Stock, Value, Issued for the quarter ending June 30, 2024 was $0.000.
Common Stock, Value, Issued, Quarterly (USD)